D-2-ヒドロキシグルタール酸性尿症患者のIDH2変異
Martijn Kranendijk1, Eduard A Struys, Emile van Schaftingen
1Metabolic Unit, Department of Clinical Chemistry, VU University Medical Center, 1081 HV Amsterdam, Netherlands.
まとめ
IDH2遺伝子の生殖系統変異は,まれな神経代謝障害であるd-2-hydroxyglutaric aciduria (D-2-HGA) を引き起こします. この発見は,代謝疾患や癌におけるD-2-HGの役割を強調しています.
科学分野:
- バイオケミストリー バイオケミストリー
- 遺伝学 遺伝学とは
- メタボリック障害 メタボリック障害
背景:
- イソチラート脱水素酵素-1と2 (IDH1/IDH2) の体内変異は,ヒトの癌と関連しています.
- これらの変異は酵素機能を変化させ,D-2-ヒドロキシグルタレート (D-2-HG) の生成につながります.
研究 の 目的:
- d-2-hydroxyglutaric aciduria (D-2-HGA) と関連したIDH2の生殖線変異を調査する.
主な方法:
- D-2-HGAを患った15人の無親の患者の遺伝分析.
- IDH2機能を評価するための酵素アッセイ.
主要な成果:
- 15人のD-2-HGA患者でIDH2の異異性菌性生殖線変異を特定した.
- 確認された変異は,IDH2酵素のArg(140) 残基を変化させる.
- 患者はD-2-HG.の超生理学的レベルを示した.
結論:
- ゲルムラインIDH2変異はD-2-HGAの原因である.
- D-2-HGの蓄積は,神経代謝障害に関与しています.
- 代謝疾患と癌におけるD-2-HGの役割に関するさらなる研究が必要である.
関連する概念動画
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...


